The most expensive, most marketed supplement cannot replace the basics
Hepatology 64 , 760773 (2016)
At GoodRx we estimate that in the last year Americans have overspent by at least $200 million by paying full retail price for their weight-loss GIP and GLP-1 agonists
Clinical trial data from Eli Lillys Phase 2 study showed that the 12mg weekly dose produced an average weight loss of 24.2% over 48 weeks, with over 80% of participants losing at least 15% of their starting body weight
A review from Anglia Ruskin University, summarized in a Knowridge analysis of GLP-1 drugs and Alzheimers prevention, looked at 30 earlier studies covering liraglutide, semaglutide, exenatide, and dulaglutide
People taking GLP-1 receptor agonists may become dehydrated from vomiting or diarrhea, causing kidney problems